Canada - English - Health Canada

great earth companies, inc. - magnesium (magnesium oxide, magnesium hvp chelate, magnesium gluconate, magnesium carbonate, magnesium ascorbate, magnesium citrate, magnesium succinate, magnesium fumarate, magnesium malate) - tablet - 188mg - magnesium (magnesium oxide, magnesium hvp chelate, magnesium gluconate, magnesium carbonate, magnesium ascorbate, magnesium citrate, magnesium succinate, magnesium fumarate, magnesium malate) 188mg - minerals

Canada - English - Health Canada

great earth companies, inc. - magnesium (magnesium oxide, magnesium hvp chelate, magnesium gluconate, magnesium carbonate, magnesium ascorbate, magnesium citrate, magnesium succinate, magnesium fumarate, magnesium malate) - tablet - 375mg - magnesium (magnesium oxide, magnesium hvp chelate, magnesium gluconate, magnesium carbonate, magnesium ascorbate, magnesium citrate, magnesium succinate, magnesium fumarate, magnesium malate) 375mg - minerals

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

unda - magnesium gluconate - sublingual solution - magnesium gluconate 0.89 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

aurum pharmaceutical limited - magnesium sulphate heptahydrate - solution for injection and concentrate for infusion - 50 percent weight/volume - electrolyte solutions; magnesium sulfate

United States - English - NLM (National Library of Medicine)

strategic sourcing services llc - magnesium citrate (unii: rho26o1t9v) (magnesium cation - unii:t6v3lhy838) - magnesium citrate 1.745 g in 29.6 ml - saline laxative for relief of occasional constipation (irregularity).  generally productes bowel movement in 1/2 to 6 hours - kidney disease - a magnesium or potassium-restricted diet - abdominal pain, nausea, or vomiting - noticed a sudden change in bowel habits that persists over a period of 2 weeks - already used a laxative for a period longer than 1 week taking any other drug.  take this product 2 or more hours before or after other drugs.  laxatives may affect how other drugs work. you have rectal bleeding or failure to have a bowel movement after use.  these could be signs of serious condition.

United States - English - NLM (National Library of Medicine)

cardinal health - magnesium citrate (unii: rho26o1t9v) (magnesium cation - unii:t6v3lhy838) - magnesium citrate 1.745 g in 29.6 mg - saline laxative for relief of occasional constipation (irregularity).  generally produces bowel movement in 1/2 to 6 hours - kidney disease - a magnesium or potassium-restricted diet - abdominal pain or nausea or vomiting - noticed a sudden change in bowel habits that persists over a period of 2 weeks - already used a laxative for a period longer than 1 week you have rectal bleeding or failure to have a bowel movement after use.  these could be signs of a serious condition.

United States - English - NLM (National Library of Medicine)

unfi - magnesium citrate (unii: rho26o1t9v) (magnesium cation - unii:t6v3lhy838) - magnesium citrate 1.745 g in 29.61 ml - saline laxative for relief of occasional constipation (irregularity). generally produces bowel movement in 1/2 to 6 hours. - kidney disease - a magnesium-restricted diet - abdominal pain, nausea or vomiting - noticed a sudden change in bowel habits that persists over a period of 2 weeks - already used a laxative for a period longer than 1 week are taking any other drug. take this product 2 or more hours before or after other drugs. laxatives may affect how other drugs work. you have rectal bleeding or failure to have a bowel movement after use. these could be signs of a serious condition.

United States - English - NLM (National Library of Medicine)

better living brands llc - magnesium citrate (unii: rho26o1t9v) (magnesium cation - unii:t6v3lhy838) - magnesium citrate 1.745 g in 29.6 ml - saline laxative for relief of occasional constipation (irregularity). generally produces bowel movement in 1/2 to 6 hours - kidney disease - a magnesium or potassium-restricted diet - abdominal pain, nausea, or vomiting - noticed a sudden change in bowel habits that persists over a period of 2 weeks - already used a laxative for a period longer than 1 week taking any other drug.  take this product 2 or more hours before or after other drugs.  laxatives may affect how other drugs work. you have rectal bleeding or failure to have a bowel movement after use. these could be signs of a serious condition.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - magnesium sulfate heptahydrate, quantity: 500 mg/ml - injection, concentrated - excipient ingredients: water for injections - parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. magnesium sulphate is also indicated in the prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia). for emegency treatment of some arrhythmias such as torsade de pointes and those associated with hypokalemia.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml - calcium gluconate injection, usp is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy.  it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage.  calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs.  in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity, provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia.  intravenous administration of calcium is contraindicated when serum calcium levels are above normal.